Physician profile
Ignis C Retief
NPI 1306825211
$1,567.52
in general payments reported to CMS, 2019-2025
13 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2021: $365 · 2022: $103 · 2023: $336 · 2024: $404 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $707.35 | 2019-2025 | Puraply, Affinity, Cygnus Dual |
| Stryker Corporation | $400.73 | 2021-2024 | Easyfuse, Anchorage, Bioskin |
| Convatec INC. | $120.98 | 2023 | |
| Paratek Pharmaceuticals, INC. | $111.77 | 2024 | Nuzyra |
| Kerecis Limited | $47.67 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $39.17 | 2019-2024 | Collagenase Santyl, Regranex |
| Medtronic, INC. | $35.43 | 2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Bioventus LLC | $25.62 | 2019 | |
| Urgo Medical North America, LLC | $15.58 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Wright Medical Technology, INC. | $14.24 | 2019 | |
| Alfasigma USA, INC. | $13.18 | 2021 | |
| Orthofix Medical, INC. | $7.23 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignis Retief listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.